home / stock / pyxs / pyxs quote
Last: | $4.34 |
---|---|
Change Percent: | 0.67% |
Open: | $4.48 |
Close: | $4.34 |
High: | $4.55 |
Low: | $4.31 |
Volume: | 228,997 |
Last Trade Date Time: | 05/10/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.34 | $4.48 | $4.34 | $4.55 | $4.31 | 228,997 | 05-10-2024 |
$4.51 | $4.26 | $4.51 | $4.55 | $4.21 | 428,133 | 05-09-2024 |
$4.27 | $4.38 | $4.27 | $4.39 | $4.18 | 435,399 | 05-08-2024 |
$4.38 | $4.31 | $4.38 | $4.54 | $4.25 | 703,939 | 05-07-2024 |
$4.31 | $4.64 | $4.31 | $4.64 | $4.26 | 349,836 | 05-06-2024 |
$4.38 | $4.5 | $4.38 | $4.78 | $4.29 | 818,440 | 05-03-2024 |
$4.41 | $4.48 | $4.41 | $4.48 | $4.31 | 189,064 | 05-02-2024 |
$4.4 | $4.44 | $4.4 | $4.7 | $4.24 | 642,989 | 05-01-2024 |
$4.45 | $4.4 | $4.45 | $4.46 | $4.38 | 123,796 | 04-30-2024 |
$4.44 | $4.37 | $4.44 | $4.63 | $4.32 | 483,932 | 04-29-2024 |
$4.3 | $4.27 | $4.3 | $4.4199 | $4.25 | 164,540 | 04-26-2024 |
$4.3 | $4.36 | $4.3 | $4.54 | $4.25 | 520,281 | 04-25-2024 |
$4.45 | $4.51 | $4.45 | $4.63 | $4.37 | 233,469 | 04-24-2024 |
$4.5 | $4.55 | $4.5 | $4.7248 | $4.435 | 384,004 | 04-23-2024 |
$4.53 | $4.22 | $4.53 | $4.69 | $4.16 | 470,313 | 04-22-2024 |
$4.16 | $4.46 | $4.16 | $4.525 | $4.06 | 668,072 | 04-19-2024 |
$4.53 | $4.86 | $4.53 | $4.86 | $4.28 | 467,908 | 04-18-2024 |
$4.83 | $4.74 | $4.83 | $5.09 | $4.74 | 585,012 | 04-17-2024 |
$4.69 | $4.63 | $4.69 | $5.01 | $4.58 | 269,496 | 04-16-2024 |
$4.74 | $4.92 | $4.74 | $4.98 | $4.64 | 434,550 | 04-15-2024 |
News, Short Squeeze, Breakout and More Instantly...
Pyxis Oncology Inc. Company Name:
PYXS Stock Symbol:
NASDAQ Market:
BOSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (NASDAQ:PYXS), a clinical stage company focused on developing next generation ther...
BOSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, announced today that Lara S. Sullivan, M.D., President and Chief Executive Officer, will participate in a...
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Re...